ConductScience.org, home

Paper346353

Does verapamil have a clinically significant antihypertensive effect?

Pedersen OL. Eur J Clin Pharmacol, 1978. Cited by 48 papers, by iCite.

Cite this record

ConductScience Library. Does verapamil have a clinically significant antihypertensive effect? Papers, record 346353. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/346353

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Does verapamil have a clinically significant antihypertensive effect?
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
48
iCite
Relative citation ratio, by iCite
2.87
iCite
Revised in PubMed
2026-10-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pedersen OLO L

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
VerapamilMajor topic
Administration, Oral
Adult
Blood Pressure
Clinical Trials as Topic
Heart Rate
Humans
Hypertension
Injections, Intravenous
Regional Blood Flow
Time Factors

Source PubMed

Download CSV of topics

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15141653The effect of verapamil on the contractility of smooth muscle and on excitation-secretion coupling in adrenergic nerve terminals.Angiologica1971https://conductscience.org/library/papers/5141653PubMed
24153535Verapamil in cardiology.Eur J Cardiol1974https://conductscience.org/library/papers/4153535PubMed
3389513Antianginal efficiency of nifedipine with and without a beta-blocker, studied with exercise test. A double-blind, randomized subacute study.Clin Cardiol1979https://conductscience.org/library/papers/389513PubMed
4414517Effects of verapamil and nitroglycerin on contractile responses to potassium and noradrenaline in isolated human peripheral veins.Acta Pharmacol Toxicol (Copenh)1978https://conductscience.org/library/papers/414517PubMed
55650138Some effects of iproveratril (Isoptin) on the cardiovascular system.J Pharmacol Exp Ther1968https://conductscience.org/library/papers/5650138PubMed
64206420[Antihypertensive effect of verapamil. Studies on and experiences with children].MMW Munch Med Wochenschr1974https://conductscience.org/library/papers/4206420PubMed
74098332[Treatment of tachycardiac arrhythmias and arterial hypertension with verapamil].Arzneimittelforschung1970https://conductscience.org/library/papers/4098332PubMed
84597950Vasodilator drugs in the treatment of hypertension.Arch Intern Med1974https://conductscience.org/library/papers/4597950PubMed
95453613[Clinical experimental studies on the blood pressure reducing effect of verapamil].Dtsch Med Wochenschr1970https://conductscience.org/library/papers/5453613PubMed
101071683Vasodilating drugs: contrasting haemodynamic effects.Clin Sci Mol Med Suppl1976https://conductscience.org/library/papers/1071683PubMed

Download CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.

PMIDTitleJournalYearIn PapersSource
7512483Postinfarct treatment with verapamil. Effect of verapamil in patients with hypertension.Drugs1993https://conductscience.org/library/papers/7512483PubMed
7002568Antihypertensive and renal effects of orally administered verapamil.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/7002568PubMed
6350692[Calcium antagonists in the therapy of hypertension].Klin Wochenschr1983https://conductscience.org/library/papers/6350692PubMed
6339198Calcium antagonists. Clinical use in the treatment of systemic hypertension.Drugs1983https://conductscience.org/library/papers/6339198PubMed
3530297The management of hypertension.Br J Clin Pharmacol1986https://conductscience.org/library/papers/3530297PubMed
3042360Drug treatment of hypertension.Drugs1988https://conductscience.org/library/papers/3042360PubMed
2966736Sustained release verapamil in renal hypertension.Eur J Clin Pharmacol1988https://conductscience.org/library/papers/2966736PubMed
1718701Treatment with verapamil after an acute myocardial infarction. Review of the Danish studies on verapamil in myocardial infarction (DAVIT I and II).Drugs1991https://conductscience.org/library/papers/1718701PubMed
738346Acute and chronic effects of nifedipine in arterial hypertension.Eur J Clin Pharmacol1978https://conductscience.org/library/papers/738346PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/346353

GET https://conductscience.org/api/papers/v1/346353/authors